Common Stock, Shares, Outstanding of Clearside Biomedical, Inc. from 31 Dec 2015 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Clearside Biomedical, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2015 to 30 Sep 2025.
  • Clearside Biomedical, Inc. Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2025 was 5,233,981, a 93% decline year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Clearside Biomedical, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 5,233,981 -69,511,591 -93% 30 Sep 2025 10-Q 14 Nov 2025 2025 Q3
Q2 2025 78,495,760 +3,764,621 +5% 30 Jun 2025 10-Q 08 Aug 2025 2025 Q2
Q1 2025 77,272,786 +2,541,647 +3.4% 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q4 2024 5,105,216 -57,745,625 -92% 31 Dec 2024 10-Q 14 Nov 2025 2025 Q3
Q3 2024 74,745,572 +12,638,261 +20% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 74,731,139 +13,013,694 +21% 30 Jun 2024 10-Q 12 Aug 2024 2024 Q2
Q1 2024 74,731,139 +13,366,840 +22% 31 Mar 2024 10-Q 10 May 2024 2024 Q1
Q4 2023 62,850,841 +2,211,014 +3.6% 31 Dec 2023 10-K 27 Mar 2025 2024 FY
Q3 2023 62,107,311 +1,916,580 +3.2% 30 Sep 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 61,717,445 +1,567,003 +2.6% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 61,364,299 +1,216,681 +2% 31 Mar 2023 10-Q 12 May 2023 2023 Q1
Q4 2022 60,639,827 +916,897 +1.5% 31 Dec 2022 10-K 12 Mar 2024 2023 FY
Q3 2022 60,190,731 +564,212 +0.95% 30 Sep 2022 10-Q 09 Nov 2022 2022 Q3
Q2 2022 60,150,442 +1,058,851 +1.8% 30 Jun 2022 10-Q 12 Aug 2022 2022 Q2
Q1 2022 60,147,618 +2,568,893 +4.5% 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q4 2021 59,722,930 +7,861,989 +15% 31 Dec 2021 10-K 14 Mar 2023 2022 FY
Q3 2021 59,626,519 +11,399,077 +24% 30 Sep 2021 10-Q 10 Nov 2021 2021 Q3
Q2 2021 59,091,591 +12,816,621 +28% 30 Jun 2021 10-Q 10 Aug 2021 2021 Q2
Q1 2021 57,578,725 +12,710,167 +28% 31 Mar 2021 10-Q 17 May 2021 2021 Q1
Q4 2020 51,860,941 +7,447,569 +17% 31 Dec 2020 10-K 11 Mar 2022 2021 FY
Q3 2020 48,227,442 +7,077,661 +17% 30 Sep 2020 10-Q 10 Nov 2020 2020 Q3
Q2 2020 46,274,970 +8,528,824 +23% 30 Jun 2020 10-Q 10 Aug 2020 2020 Q2
Q1 2020 44,868,558 +8,085,638 +22% 31 Mar 2020 10-Q 08 May 2020 2020 Q1
Q4 2019 44,413,372 +12,294,145 +38% 31 Dec 2019 10-K 15 Mar 2021 2020 FY
Q3 2019 41,149,781 +9,125,558 +28% 30 Sep 2019 10-Q 08 Nov 2019 2019 Q3
Q2 2019 37,746,146 +5,721,923 +18% 30 Jun 2019 10-Q 08 Aug 2019 2019 Q2
Q1 2019 36,782,920 +4,835,887 +15% 31 Mar 2019 10-Q 10 May 2019 2019 Q1
Q4 2018 32,119,227 +6,764,576 +27% 31 Dec 2018 10-K 13 Mar 2020 2019 FY
Q3 2018 32,024,223 +6,681,778 +26% 30 Sep 2018 10-Q 08 Nov 2018 2018 Q3
Q2 2018 32,024,223 +6,687,741 +26% 30 Jun 2018 10-Q 08 Aug 2018 2018 Q2
Q1 2018 31,947,033 +6,647,017 +26% 31 Mar 2018 10-Q 10 May 2018 2018 Q1
Q4 2017 25,354,651 +781,618 +3.2% 31 Dec 2017 10-K 15 Mar 2019 2018 FY
Q3 2017 25,342,445 +4,796,693 +23% 30 Sep 2017 10-Q 09 Nov 2017 2017 Q3
Q2 2017 25,336,482 +5,742,180 +29% 30 Jun 2017 10-Q 11 Aug 2017 2017 Q2
Q1 2017 25,300,016 31 Mar 2017 10-Q 10 May 2017 2017 Q1
Q4 2016 24,573,033 +21,913,771 +824% 31 Dec 2016 10-K 16 Mar 2018 2017 FY
Q3 2016 20,545,752 30 Sep 2016 10-Q 14 Nov 2016 2016 Q3
Q2 2016 19,594,302 30 Jun 2016 10-Q 12 Aug 2016 2016 Q2
Q4 2015 2,659,262 31 Dec 2015 10-K 16 Mar 2017 2016 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.